secwatch.observer — SEC 8-K summary
======================================

Issuer:     STANDARD BIOTOOLS INC. (LAB)
CIK:        0001162194
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001193125-26-177290
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Standard BioTools receives Nasdaq bid price deficiency notice; 180-day cure period through Oct 19, 2026
--------------------------------------------------------------------------------

- Notice on April 20, 2026: common stock closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until October 19, 2026) to regain compliance by maintaining $1.00 closing bid for 10 consecutive days.
- If eligible, company may transfer to Nasdaq Capital Market for an additional 180-day cure period, subject to fees and conditions.
- Trading under ticker LAB continues uninterrupted; no effect on business operations or SEC reporting.
- Company intends to cure, but no assurance of regaining compliance or extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1162194/000119312526177290/0001193125-26-177290-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1162194/000119312526177290/lab-20250913.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-177290

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer